Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years.

Prognostic factors have been examined in 644 patients with tumor-node-metastasis (TNM) stage T1 breast carcinoma treated by mastectomy and followed for a median of 18.2 years. Overall, 148 patients (23%) died of recurrent breast carcinoma. Eighteen (3%) were alive with recurrent disease and 478 (74%) were alive or died of other causes without recurrence. Unfavorable clinicopathologic features were larger tumor size (1.1 to 2.0 cm v less than or equal to 1 cm), perimenopausal menstrual status, the number of axillary lymph node metastases, poorly differentiated grade, presence of lymphatic tumor emboli (LI) in breast tissue near the primary tumor, blood vessel invasion (BVI), and an intense lymphoplasmacytic reaction around the tumor. Median survival after recurrence for the entire series was 2 years. This was not significantly influenced by tumor size, the number of axillary nodal metastases, the type of treatment for recurrence, or the interval to recurrence. The proportions surviving 5 and 10 years after recurrence were 17% and 5%, respectively. Among T1N0M0 cases, the chance of a local recurrence was 2.8% within 20 years. Median survival of T1N0M0 cases after local recurrence (4.5 years) was significantly longer than after systemic recurrence (1.5 years). A similar trend (3.7 v 2.0 years), not statistically significant, was seen in T1N1M0 patients, who had a 6.5% chance of local recurrence within 20 years. Median survival following systemic recurrence detected 10 or more years after diagnosis in T1N0M0 and in T1N1M0 patients was significantly longer than the median survival for systemic recurrences found in the first decade of follow-up. This difference did not apply following local recurrence in either T1N0M0 or T1N1M0 cases. It is evident that patients with T1 breast carcinoma can be subdivided into differing prognostic groups and this must be taken into account when considering the role of adjuvant chemotherapy for stage I disease. Systemic adjuvant treatment may prove to be beneficial for patients with unfavorable prognostic factors, while women with an especially low risk for recurrence (eg, T1N0M0 tumor 1.0 cm or less) might be spared such treatment.

[1]  S. Groshen,et al.  Contralateral breast carcinoma: an assessment of risk and prognosis in stage I (T1N0M0) and stage II (T1N1M0) patients with 20-year follow-up. , 1989, Surgery.

[2]  S. Groshen,et al.  Nonmammary Malignant Neoplasms in Patients with Stage I (T1N0M0) and Stage II (T1N1M0) Breast Carcinoma: A Long‐Term Follow‐Up Study , 1989, American journal of clinical oncology.

[3]  P. Saigo,et al.  A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  Henson De The histological grading of neoplasms. , 1988 .

[5]  T. Powles,et al.  Development and Use of a Natural History Data Base of Breast Cancer Studies , 1987, American journal of clinical oncology.

[6]  M. Bignardi,et al.  Analysis of prognostic factors in patients with isolated chest wall recurrence of breast cancer , 1987, Cancer.

[7]  J. Hermans,et al.  An evaluation of routine follow‐up for detection of breast cancer recurrences , 1987, Journal of surgical oncology.

[8]  P. Saigo,et al.  The application of immunohistochemical stains to identify endothelial‐lined channels in mammary carcinoma , 1987, Cancer.

[9]  R. Gelber,et al.  Prognostic significance of tumor grade in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis , 1986, Cancer.

[10]  J. Rosenman,et al.  Local recurrences in patients with breast cancer at the North Carolina memorial hospital (1970–1982) , 1986, Cancer.

[11]  J. Harris,et al.  Observations on survival curve analysis with particular reference to breast cancer treatment , 1986, Cancer.

[12]  P. Hietanen Relapse pattern and follow-up of breast cancer. , 1986, Annals of clinical research.

[13]  L. Rutqvist On the utility of the lognormal model for analysis of breast cancer survival in Sweden 1961-1973. , 1985, British Journal of Cancer.

[14]  P. Sismondi,et al.  Early Detection of Breast Cancer Recurrences through Periodic follow-up - is it Useless? , 1985, Tumori.

[15]  J. Cuzick,et al.  Which patients are cured of breast cancer? , 1984, British medical journal.

[16]  S. Koscielny,et al.  Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination. , 1984, British Journal of Cancer.

[17]  S. Ciatto,et al.  The Role of Chest X-Ray in the Follow-Up of Primary Breast Cancer , 1983, Tumori.

[18]  Rosen Pp Tumor emboli in intramammary lymphatics in breast carcinoma: pathologic criteria for diagnosis and clinical significance. , 1983 .

[19]  T. Brøyn,et al.  Evaluation of routine follow-up after surgery for breast carcinoma. , 1982, Acta chirurgica Scandinavica.

[20]  P. Saigo,et al.  Prognosis in Stage II “T1N1M0”Breast Cancer , 1981, Annals of surgery.

[21]  Rupert G. Miller,et al.  Survival Analysis , 2022, The SAGE Encyclopedia of Research Design.

[22]  P. Saigo,et al.  Predictors of recurrence in stage I (T1N0M0) breast carcinoma. , 1981, Annals of surgery.

[23]  G. Bonadonna,et al.  Patterns of relapse and survival following radical mastectomy. Analysis of 716 consecutive patients , 1978, Cancer.

[24]  H. Thaler,et al.  Prognostic significance of tumor emboli in intramammary lymphatics in patients with mammary carcinoma , 1977, The American journal of surgical pathology.

[25]  F. Schabel Concepts for systemic treatment of micrometastases , 1975, Cancer.

[26]  G. Robbins,et al.  Long‐term followup of breast cancer patients: The 30‐year report , 1974, Cancer.

[27]  I D Bross,et al.  Cancer of the breast: Size of neoplasm and prognosis , 1969, Cancer.

[28]  Berg Jw,et al.  Factors influencing short and long term survival of breast cancer patients. , 1966 .

[29]  W. Donegan,et al.  A biostatistical study of locally recurrent breast carcinoma. , 1966, Surgery, gynecology & obstetrics.

[30]  R. Greenberg,et al.  Survival of breast-cancer patients in Connecticut, 1935-54. , 1959, Journal of the National Cancer Institute.

[31]  H. Bloom,et al.  Histological Grading and Prognosis in Breast Cancer , 1957, British Journal of Cancer.